Search for: "Generic Pharmaceutical Association" Results 21 - 40 of 3,014
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Aug 2012, 10:29 am by Allison Zieve
The Generic Pharmaceutical Association has this report today on "Generic Drug Savings in the U.S. [read post]
6 Sep 2018, 6:14 am by Robert Kraft
Fierce Healthcare reports Humana “filed a lawsuit against more than two dozen pharmaceutical companies for conspiring to fix the prices of widely used generic drugs. [read post]
21 May 2008, 3:00 am
  Our latest article takes a brief look at the issues and summarises Duncan's presentation on 21 May at the Australian Generic Medicines Association conference in Sydney. [read post]
19 Jan 2010, 11:12 pm by Michael Geist
Continuing the review of submissions to DFAIT regarding the Canada-EU Trade Agreement, the Canadian Generic Pharmaceutical Association warned against the inclusion of any intellectual property provisions: The very fact that both Canada and EU have robust IP systems in place should be a sufficient basis on which to enhance and expand our existing trade relationship. [read post]
25 Aug 2006, 2:46 pm
If you're familiar with the drug industry, it should come as no great shock that the Generic Pharmaceutical Association (GPhA) disagrees with a report put out by the Pharmaceutical Research and Manufacturers of America (PhRMA). [read post]
4 Jun 2020, 6:14 am by Wim Vandenberghe
The pandemic merely highlights the international dimension of the pharmaceutical manufacturing and supply activities and associated risks if there is a (serious) hitch in the supply chain. [read post]
1 Jun 2011, 6:15 am by Brian A. Comer
South Carolina Attorney General Alan Wilson has brought another lawsuit against a pharmaceutical manufacturer. [read post]
16 Jul 2007, 9:46 pm
Among those submitting comments were the Biotechnology Industry Association (BIO) (here), Intellectual Property Owners Association... [read post]
31 Jul 2006, 8:38 pm
The Generic Pharmaceutical Association (GPhA), the trade group representing generic drug makers, released a study today concluding that authorized generics do not save consumers money and ultimately will lead to higher drug prices. [read post]
26 Dec 2011, 1:38 pm by mikedavidson
The generic version, called Ventura, is marketed and sold by Watson Pharmaceuticals. [read post]
27 Sep 2007, 7:22 pm
This bill makes crystal clear that regardless of FDA approval, the duty to warn remains with the pharmaceutical companies to adequately provide a meaningful warning about the risks associated with the use of their product. [read post]
27 Sep 2007, 7:22 pm
This bill makes crystal clear that regardless of FDA approval, the duty to warn remains with the pharmaceutical companies to adequately provide a meaningful warning about the risks associated with the use of their product. [read post]
24 Mar 2022, 12:04 pm by Zak Gowen
District Court for the Eastern District of California granted the motion of a trade association of pharmaceutical manufacturers—the Association for Accessible Medicines’ (“AAM”)—to enjoin AB 824 on the grounds that it likely violated the U.S. [read post]
7 Sep 2011, 5:42 am
Neas, a longtime advocate for liberal causes and the face of some of the biggest Supreme Court nomination fights in recent decades, has been named the new chief executive of the Generic Pharmaceutical Association, a Washington-based industry group representing generic drug makers and suppliers. [read post]
22 Mar 2016, 4:00 am by Paula Bremner
The annual US Generic Pharmaceutical Association meeting in February, despite being held in Orlando, was generally not a sunny affair. [read post]
13 Apr 2022, 6:42 am by greggshapiro.admin
This practice can be particularly remunerative for pharmaceutical companies that sell drugs for rare diseases associated with specific genetic mutations. [read post]
4 Apr 2019, 12:57 pm by Brianna Bell
Lundbeck sells Xenazine, which was the exclusive drug to treat chorea associated with Huntington’s Disease, until a generic version was created in 2015. [read post]
1 Apr 2024, 10:58 am by Dennis Crouch
  Overall, this is a bad case for pharmaceutical formulary patents. [read post]